Study finds evidence for repurposing thiostrepton as an anti-rhabdomyosarcoma drug Post author:admin Post published:October 27, 2025 Post category:uncategorized Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas. You Might Also Like Post-Brexit drop in EU nurses linked to increased patient deaths July 16, 2026 FDA-approved iron-chelating drug could provide a novel way to attack ovarian tumors July 29, 2024 Global meningitis deaths remain high despite progress since 1990 March 27, 2026